Skip to main content
OpenTrials

Clinical trial condition

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Explore clinical trials studying Philadelphia Chromosome Positive Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia trial results

Completed

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

NCT01456676

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Frankfurt, Germany
  • Novartis Investigative Site Ulm, Germany
View Trial Details

Related conditions